Surgical septal myectomy is the treatment of choice for patients with symptomatic hypertrophic obstructive cardiomyopathy refractory to medications. This report describes our minimally invasive approach for performing a septal myectomy via a ministernotomy that has been used at our institution for more than a decade. In particular, patient preparation, surgical technique, and clinical considerations are highlighted. Performed properly, this minimally invasive technique is a feasible and effective approach in our experience.
OmmenS.R., MaronB.J., OlivottoI.Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol.2005; 46: 470–176.
GilmanovD.S., BevilacquaS., SolinasM.Minimally invasive septal myectomy for the treatment of hypertrophic obstructive cardiomyopathy and intrinsic mitral valve disease. Innovations.2015; 10: 106–113.
4.
KhalpeyZ., KorovinL., ChitwoodW.R.Jr., PostonR.Robot-assisted septal myectomy for hypertrophic cardiomyopathy with left ventricular outflow tract obstruction. J Thorac Cardiovasc Surg.2014; 147: 1708–1709.
5.
MazineA., GhoneimA., BouhoutI.A novel minimally invasive approach for surgical septal myectomy. Can J Cardiol.2016; 32: 1340–1347.
6.
KirmaniB.H., JonesS.G., MalaisrieS.C., ChungD.A., WilliamsR.J.Limited versus full sternotomy for aortic valve replacement. Cochrane Database Syst Rev.2017; 4: CD011793.
7.
Authors/Task Force members, ElliottP.M., AnastasakisA., BorgerM.A.2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J.2014; 35: 2733–2779.
